ANDA 84351, held by IVAX Pharmaceuticals. Brompheniramine Maleate.
As of Nov 21, 2026, ANDA 84351 (Brompheniramine Maleate), held by IVAX Pharmaceuticals, was first approved by FDA on Dec 17, 1975, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 17, 1975 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Brompheniramine Maleate4MG · tablet;oral | Brompheniramine Maleate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters